Hosseini, Pooria
Eghbali, Areian
Pawelek, Jeff
Heskett, Karen
Mundis, Gregory M.
Akbarnia, Behrooz A.
Article History
Received: 10 March 2018
Accepted: 13 October 2019
First Online: 8 January 2020
Compliance with ethical standards
:
: Behrooz A. Akbarnia: Nuvasive, K2M, DePuy Synthes (a), Nuvasive (d), Nuvasive (f), Nuvasive (g), GSF, SDSF, SRS, SOLAS (h). Gregory M. Mundis: Nuvasive (a, d, g), K2M (a,d), Allosource (d), ISSGF (g), SOLAS, SRS, SDSF, GSO (h). For the remaining authors none were declared. (a) Royalties (b) Speakers bureau/paid presentations (c) Paid employee (d) Paid consultant (e) Unpaid consultant (f) Stock or stock options (g) Research support from a company or supplier as a PI (h) Board member/committee appointments for a society (i) Other financial or material support.
: Both TGR and MCGR are FDA approved.